1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Rotigotine
Trade Name:
Neupro
Manufacturer/Distributor:
UCB Canada Inc.
www.ucb.com 1-877-504-7363
Classification:
Antiparkinsonian agent / Dopamine agonist
ATC Class:
N02BX - Other dopaminergic agents
Status:
active
Notice of Compliance (yyyy/mm/dd):
2012/03/21
Date Marketed in Canada (yyyy/mm/dd):
2013/09/12
Presentation:
Transdermal patch: 1 mg/24 hr. DIN: 02403897
Transdermal patch: 2 mg/24 hr. DIN: 02403900
Transdermal patch: 3 mg/24 hr. DIN:02403919
Transdermal patch: 4 mg/24 hr. DIN: 02403927
Transdermal patch: 6 gm/24 hr. DIN: 02403935
Transdermal patch: 8 mg/24 hr. DIN: 02403943
Comments:
Rotigotine is used for treatment of signs and symptoms of idiopathic Parkinson's disease. It may be used both as early therapy, without concomitant levodopa, or as an adjunct to levodopa.
This medication has also been approved to treatment of moderate to severe idiopathic restless legs syndrome.
Back to:
Drug Product Listings 
